Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers.
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …
Anthem Inc (NYSE:ANTM), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that it …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today the …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) successfully completed foundational phases of development of an antibody construct labeled with actinium-225 using the Company’s novel proprietary APIT …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it entered …
Actinium Pharmaceuticals Inc (NYSE MKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that the presentation …
Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, recently sponsored the 9 th …